Ami Asset Management Corp Ligand Pharmaceuticals Inc Transaction History

Ami Asset Management Corp

$1.8 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$68.64 - $89.2 $115,864 - $150,569	-1,688 Reduced 3.96%	40,931 $2.99 Million
Q4 2023 Jan 19, 2024	BUY	$49.57 - $72.63 $430,416 - $630,646	8,683 Added 25.59%	42,619 $3.04 Million
Q3 2023 Oct 20, 2023	SELL	$58.86 - $72.67 $668,649 - $825,531	-11,360 Reduced 25.08%	33,936 $2.03 Million
Q2 2023 Jul 24, 2023	BUY	$69.53 - $79.33 $1.21 Million - $1.38 Million	17,404 Added 62.4%	45,296 $3.27 Million
Q1 2023 Apr 20, 2023	BUY	$65.67 - $77.08 $460,675 - $540,716	7,015 Added 33.6%	27,892 $2.05 Million
Q4 2022 Jan 17, 2023	SELL	$61.72 - $96.74 $459,320 - $719,939	-7,442 Reduced 26.28%	20,877 $1.4 Million
Q3 2022 Oct 24, 2022	SELL	$0.01 - $107.56 $135 - $1.45 Million	-13,510 Reduced 32.3%	28,319 $2.44 Million
Q2 2022 Jul 21, 2022	SELL	$74.52 - $117.06 $53,803 - $84,517	-722 Reduced 1.7%	41,829 $3.73 Million
Q1 2022 Apr 27, 2022	BUY	$94.99 - $151.56 $198,339 - $316,457	2,088 Added 5.16%	42,551 $4.79 Million
Q4 2021 Jan 20, 2022	SELL	$127.69 - $165.85 $1.13 Million - $1.47 Million	-8,834 Reduced 17.92%	40,463 $6.25 Million
Q3 2021 Oct 22, 2021	BUY	$102.33 - $144.73 $171,402 - $242,422	1,675 Added 3.52%	49,297 $6.87 Million
Q2 2021 Jul 20, 2021	BUY	$113.03 - $155.64 $83,190 - $114,551	736 Added 1.57%	47,622 $6.25 Million
Q1 2021 Apr 16, 2021	SELL	$99.52 - $215.83 $1.19 Million - $2.58 Million	-11,939 Reduced 20.3%	46,886 $7.15 Million
Q4 2020 Jan 20, 2021	SELL	$80.55 - $106.05 $3.47 Million - $4.56 Million	-43,043 Reduced 42.25%	58,825 $5.85 Million
Q3 2020 Oct 23, 2020	SELL	$89.56 - $126.72 $177,239 - $250,778	-1,979 Reduced 1.91%	101,868 $9.71 Million
Q2 2020 Jul 15, 2020	BUY	$68.28 - $123.65 $784,946 - $1.42 Million	11,496 Added 12.45%	103,847 $11.6 Million
Q1 2020 Apr 27, 2020	SELL	$63.37 - $107.88 $78,642 - $133,879	-1,241 Reduced 1.33%	92,351 $6.72 Million
Q4 2019 Jan 23, 2020	SELL	$96.94 - $113.59 $801,209 - $938,821	-8,265 Reduced 8.11%	93,592 $9.76 Million
Q3 2019 Oct 23, 2019	SELL	$86.25 - $120.16 $1.69 Million - $2.36 Million	-19,634 Reduced 16.16%	101,857 $10.1 Million
Q2 2019 Aug 05, 2019	BUY	$107.38 - $129.34 $2.2 Million - $2.65 Million	20,483 Added 20.28%	121,491 $13.9 Million
Q1 2019 Apr 25, 2019	BUY	$105.93 - $142.47 $1.96 Million - $2.64 Million	18,548 Added 22.49%	101,008 $12.7 Million
Q4 2018 Jan 25, 2019	BUY	$128.36 - $272.13 $2.54 Million - $5.39 Million	19,820 Added 31.64%	82,460 $11.2 Million
Q3 2018 Oct 23, 2018	SELL	$211.18 - $274.49 $5.5 Million - $7.15 Million	-26,052 Reduced 29.37%	62,640 $17.2 Million
Q2 2018 Jul 23, 2018	SELL	$150.77 - $207.98 $2.71 Million - $3.74 Million	-17,967 Reduced 16.85%	88,692 $18.4 Million
Q1 2018 Apr 20, 2018	SELL	$138.63 - $182.62 $2.12 Million - $2.79 Million	-15,305 Reduced 12.55%	106,659 $17.6 Million
Q4 2017 Jan 16, 2018	SELL	$128.36 - $147.04 $2.41 Million - $2.76 Million	-18,794 Reduced 13.35%	121,964 $16.7 Million
Q3 2017 Oct 10, 2017	BUY	$120.91 - $137.94 $17 Million - $19.4 Million	140,758	140,758 $19.2 Million

Others Institutions Holding LGND

# of Institutions

255

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.82B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ami Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Ami Asset Management Corp with notifications on news.

Account